Research and knowledge are the key to addressing global challenges relating to health, climate and the environment. Highly capable researchers and clinicians from all over Norway report ideas and discoveries to us. We develop and manage these ideas, and proceed with the ones that can be transformed into products and services that benefit society.
We have started businesses that develop better cancer therapies, combat antibiotic resistance and identify security breaches in complex IT systems. Two-thirds of our businesses and licenses are in the field of life science, since our ecosystem is especially strong in that field.
Another important task we perform is to administer agreements on clinical trials on behalf of the hospitals in our region. We make active endeavours to get more international companies to carry out their clinical trials in Norway. That way, more innovative treatment can benefit more patients in Norway.
Please contact us for licensing opportunities and for setting up clinical trials in Norway.
Inven2 is a limited company owned by the University of Oslo and Oslo University Hospital.